19 results on '"Low, Audrey"'
Search Results
2. Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
3. P003 An audit of the uptake of vaccinations against influenza, pneumonia and varicella zoster among rheumatology outpatients
4. P071 Survey of rheumatology patient satisfaction with telephone consultations during the COVID-19 pandemic
5. Site-specific incorporation of 5′-methyl DNA enhances the therapeutic profile of gapmer ASOs
6. P03 Effectiveness and tolerability of Benepali in patients switched from Enbrel with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthropathy
7. Service evaluation of one-stop provision of diagnostic ultrasound, drug education and therapy services in an early inflammatory arthritis clinic in Salford
8. Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides
9. Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
10. Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primates
11. Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins
12. 095 Development of an occupational therapy advanced practitioner role within a multidisciplinary early inflammatory arthritis clinic in Salford
13. 190 Multicentre survey of patient attitudes towards tapering of biologic drugs
14. 096 Service evaluation of one-stop provision of diagnostic ultrasound, drug education and therapy services in an early inflammatory arthritis clinic in Salford
15. 001 A prospective audit of a patient cohort prescribed hydroxychloroquine in order to estimate the burden of retinopathy screening and service requirements for drug education appointments
16. 073 Barriers to biologic dose tapering in rheumatoid arthritis
17. THE BSR BIOLOGICS REGISTERS: SCIENTIFIC UPDATE AND RECENT FINDINGSI120. CARDIOVASCULAR CO-MORBIDITY AMONG PATIENTS RECEIVING TUMUOR NECROSIS FACTOR INHIBITOR FOR RHEUMATOID ARTHRITIS
18. Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor
19. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.